Practical Guide to EU Funding for Research, Development & Innovation

The EU supports research and innovation activities through a range of programmes, including the Seventh Framework Programme for Research (FP7), the Competitiveness and Innovation Programme (CIP) and Structural Funds. Now the European Commission is developing a guide to help researchers select the right programme for their activities and even combine funds from different sources. A draft version of the guide is now ready and the Commission is keen to receive feedback on the document from the research community.

At the heart of the guide is a six-point checklist designed to help researchers identify the most relevant funding source for their needs. Questions cover the eligibility of the organisation or company, the eligibility of the planned activity, the timeframe for the project, the type of financial support needed and the identity of any other partners involved.

With a budget of over €50 billion for the period 2007 to 2013, FP7 is the EU's main instrument for the support of research and development activities. Meanwhile the €3.6 billion CIP initiative aims to boost the competitiveness of European businesses, with a focus on eco-innovation, information and communication technologies (ICTs) and renewable energies and energy efficiency.

Structural Funds are designed to reduce disparities in the level of development among regions and Member States. Although the amount of funding allocated to research and innovation varies from region to region, it is estimated that the total amount allocated to these activities will top the €99 billion mark for the period 2007 to 2013.

The guide explains how funds from these three sources can be combined to best effect, without falling foul of co-financing rules (which require recipients of most EU funds to finance part of their project from non-EU sources). The trick, according to the guide, is to use complementary financing.

"For example, separate but related activities or parts of a project can be funded by the Structural Funds, FP7 or the CIP," the guide reads. "Equally, the different funding sources may support different phases of the development of a technology over time, starting from basic research, to applied research, to demonstration or to pre-competitive market introduction."

A series of examples illustrates how different organisations might draw on different funds for different activities or phases of their projects.

The guide also notes that now is a good time to combine funds from these three sources. They share a common timeframe (2007 to 2013), and thanks to the Lisbon Strategy, research and innovation are now seen as crucial for regional development, a fact which is reflected in the Structural Funds. At the same time, the role of the regions in research is taken into account in both FP7 and CIP.

The Commission is keen to receive comments and suggestions by the end of April on how the guide can be made even more practical and user-friendly. Once finalised, the online version of the guide will be updated regularly and will also include links to the relevant national and regional programmes.

For further information, and a copy of the draft Practical Guide, please visit:
http://cordis.europa.eu/eu-funding-guide/home_en.html

Copyright ©European Communities, 2008
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

A Novel AI-Based Method Reveals How Cell…

Researchers from Tel Aviv University have developed an innovative method that can help to understand better how cells behave in changing biological environments, such as those found within a cancerous...